Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON

TAYSHA GENE THERAPIES, INC.

(TSHA)
Prezzo stimato in tempo reale. Tempo reale stimato Cboe BZX - 28/09 16:04:22
20.045 USD   -1.01%
16/07TAYSHA GENE THERAPIES, INC.: Needham & Co. ottimista sul caso
MM
24/06TAYSHA GENE THERAPIES, INC.: Truist Securities è per il Buy
MM
15/06TAYSHA GENE THERAPIES, INC.: giudizio positivo da BTIG
MM
RiassuntoQuotazioniGraficiNotizieRatingAgendaSocietąFinanzaConsensusRevisioniDerivati 
RiassuntoTutte le notizieRaccomandazione analistiAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su TAYSHA GENE THERAPIES, INC.
22/09TAYSHA GENE THERAPIES: Receives EU Orphan Drug Designation for TSHA-102 for Rett Syndrome
22/09TAYSHA GENE THERAPIES: Receives Orphan Drug Designation from the European Commission for ..
15/09TAYSHA GENE THERAPIES ANNOUNCES PUBL: Methods & Clinical Development
15/09TAYSHA GENE THERAPIES ANNOUNCES PUBL: Methods & Clinical Development
08/09TAYSHA GENE THERAPIES: to Host Key Opinion Leader Webinar on TSHA-102 for the Treatment o..
01/09TAYSHA GENE THERAPIES: to Participate in Upcoming September Investor Healthcare Conferenc..
25/08SECTOR UPDATE: Health Care Stocks Mixed Pre-Bell Wednesday
25/08Taysha Gene Therapies Gets Europe Orphan Drug Designation for Epilepsy Treatment
25/08TAYSHA GENE THERAPIES: Says Epilepsy Treatment Gets Orphan Drug Designation From European..
25/08TAYSHA GENE THERAPIES: Receives Orphan Drug Designation for TSHA-105 for the Treatment of..
17/08TAYSHA GENE THERAPIES: to Host Key Opinion Leader Webinar on TSHA-118 for the Treatment o..
16/08TAYSHA GENE THERAPIES: Management's Discussion and Analysis of Financial Condition and Re..
16/08TAYSHA GENE THERAPIES': Q2 Loss Narrows, Operating Expenses Rise; Secures Up to $100 Mill..
16/08TAYSHA GENE THERAPIES: Reports Second Quarter 2021 Financial Results and Provides Corpora..
16/08TAYSHA GENE THERAPIES, INC.: Results of Operations and Financial Condition, Regulation FD..
16/08TAYSHA GENE THERAPIES: Reports Second Quarter 2021 Financial Results and Provides Corpora..
16/08TAYSHA GENE THERAPIES: Secures up to $100 Million Non-Dilutive Term Loan Financing
16/08Taysha Gene Therapies, Inc. Reports Consolidated Unaudited Earnings Results for the Sec..
16/08Taysha Gene Therapies, Inc. Secures Up to $100 Million Non-Dilutive Term Loan Financing
16/08NORTH AMERICAN MORNING BRIEFING: Weak Chinese -3-
09/08TAYSHA GENE THERAPIES: to Release Second Quarter 2021 Financial Results and Host Conferen..
02/08TAYSHA GENE THERAPIES: to Participate in Upcoming August Investor Healthcare Conferences
20/07TAYSHA GENE THERAPIES: to Host Manufacturing Day
08/07TAYSHA GENE THERAPIES: to Participate in Upcoming July Investor Healthcare Conference
30/06TAYSHA GENE THERAPIES: View Presentation - Day 2
28/06TAYSHA GENE THERAPIES: View Presentation - Day 1
28/06TAYSHA GENE THERAPIES, INC.: Regulation FD Disclosure, Financial Statements and Exhibits ..
25/06TAYSHA GENE THERAPIES, INC.(NASDAQGS: TSHA) added to Russell Microcap Growth Index
25/06TAYSHA GENE THERAPIES, INC.(NASDAQGS: TSHA) added to Russell 3000E Index
25/06TAYSHA GENE THERAPIES, INC.(NASDAQGS: TSHA) added to Russell 3000E Value Index
25/06TAYSHA GENE THERAPIES, INC.(NASDAQGS: TSHA) added to Russell 3000E Growth Index
25/06TAYSHA GENE THERAPIES, INC.(NASDAQGS: TSHA) added to Russell Microcap Value Index
25/06TAYSHA GENE THERAPIES, INC.(NASDAQGS: TSHA) added to Russell Microcap Index
21/06TAYSHA GENE THERAPIES: Announces Publication of Natural History Data for TSHA-120 in Gian..
18/06TAYSHA GENE THERAPIES: June 2021 Corporate Presentation
17/06TAYSHA GENE THERAPIES, INC.: Submission of Matters to a Vote of Security Holders (form 8-..
17/06TAYSHA GENE THERAPIES: to Host Virtual R&D Day
15/06TAYSHA GENE THERAPIES: to Participate in Upcoming Investor Healthcare Conference and CEO ..
10/06TAYSHA GENE THERAPIES: to Host First Annual Stockholder Meeting
26/05TAYSHA GENE THERAPIES: to Participate in Upcoming June Investor Healthcare Conferences
19/05TAYSHA GENE THERAPIES: Joins the Rare Disease Company Coalition
17/05TAYSHA GENE THERAPIES: Insider Trading Report (SEC Filing - 4)
13/05TAYSHA GENE THERAPIES: Expands Leadership Team with the Appointment of Chief Development ..
13/05Taysha Gene Therapies Appoints Mary Newman as Chief Development Officer
13/05TAYSHA GENE THERAPIES: to Participate in Upcoming May Investor Healthcare Conferences
12/05TAYSHA GENE THERAPIES: Reports First Quarter 2021 Financial Results and Provides a Corpor..
11/05TAYSHA GENE THERAPIES: Management's Discussion and Analysis of Financial Condition and Re..
11/05TAYSHA GENE THERAPIES: Posts Wider Q1 Net Loss
11/05TAYSHA GENE THERAPIES, INC.: Results of Operations and Financial Condition, Financial Sta..
11/05TAYSHA GENE THERAPIES: Reports First Quarter 2021 Financial Results and Provides a Corpor..
11/05Taysha Gene Therapies, Inc. Reports Consolidated Unaudited Earnings Results for the Thr..
10/05TAYSHA GENE THERAPIES: Announces Publication of Preclinical Data for TSHA-102 in Rett Syn..
10/05Taysha Gene Therapies, Inc. Announces Publication of Preclinical Data for TSHA-102 in R..
05/05TAYSHA GENE THERAPIES: Announces Multiple Data Presentations and Workshop Presentations a..
04/05TAYSHA GENE THERAPIES: to Release First Quarter 2021 Financial Results and Host Conferenc..
14/04TAYSHA GENE THERAPIES, INC.: Regulation FD Disclosure, Other Events, Financial Statements..
14/04TAYSHA GENE THERAPIES: Announces New Data on Multiple Preclinical Programs and Upcoming R..
14/04Taysha Gene Therapies Announces New Data on Multiple Preclinical Programs
12/04TAYSHA GENE THERAPIES: Secures Rights to AAV9 Gene Therapy Program
12/04TAYSHA GENE THERAPIES, INC.: Other Events, Financial Statements and Exhibits (form 8-K)
12/04TAYSHA GENE THERAPIES: Acquires Exclusive Worldwide Rights to Clinical-Stage AAV9 Gene Th..
12/04Taysha Gene Therapies, Inc. Gene Therapies Acquires Worldwide Rights to Clinical-Stage ..
12/04Taysha Gene Therapies, Inc. acquired Exclusive Worldwide Rights to Clinical-Stage AAV9 ..
05/04TAYSHA GENE THERAPIES: to Participate in Upcoming April Investor Healthcare Conferences
24/03Certain Options of Taysha Gene Therapies, Inc. are subject to a Lock-Up Agreement Endin..
24/03Certain Restricted Stock Units of Taysha Gene Therapies, Inc. are subject to a Lock-Up ..
24/03Certain Common Stock of Taysha Gene Therapies, Inc. are subject to a Lock-Up Agreement ..
22/03TAYSHA GENE THERAPIES, INC.(NASDAQGS: TSHA) added to S&P Global BMI Index
11/03TAYSHA GENE THERAPIES: Announces Participation in Upcoming March Investor Healthcare Conf..
09/03TAYSHA GENE THERAPIES: Teams Up With Yale Researchers to Develop Gene Therapy for Neurode..
09/03TAYSHA GENE THERAPIES, INC.: Other Events, Financial Statements and Exhibits (form 8-K)
09/03TAYSHA GENE THERAPIES: Announces Collaboration to Advance Next-Generation Mini-Gene Paylo..
09/03Taysha Gene Therapies, Inc. Announces Collaboration to Advance Next-Generation Mini-Gen..
05/03TAYSHA GENE THERAPIES: Results of Operations and Financial Condition, Financial Statement..
03/03TAYSHA GENE THERAPIES: Reports 2020 Net Loss
1  2  3Pross.
Prossimo evento su TAYSHA GENE THERAPIES, INC.
27/09/21